{
    "2019-03-27": [
        [
            {
                "time": "",
                "original_text": "白雲山(600332.SH)：頭孢呋辛酯片通過仿製藥一致性評價",
                "features": {
                    "keywords": [
                        "白雲山",
                        "頭孢呋辛酯片",
                        "仿製藥",
                        "一致性評價"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "醫藥"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "白雲山：整合完成，重新出發",
                "features": {
                    "keywords": [
                        "白雲山",
                        "整合",
                        "重新出發"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "綜合企業"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}